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Introduction: Long–standing disparities in colorectal cancer (CRC) outcomes and
survival between Whites and Blacks have been observed. A person–centered approach
using latent class analysis (LCA) is a novel methodology to assess and address CRC
health disparities. LCA can overcome statistical challenges from subgroup analyses that
would normally impede variable–centered analyses like regression. Aim was to identify
risk profiles and differences in malignant CRC survivorship outcomes.
Methods: We conducted an LCA on the Surveillance, Epidemiology, and End Results
data from 1975 to 2016 for adults ≥18 (N = 525,245). Sociodemographics used
were age, sex/gender, marital status, race, and ethnicity (Hispanic/Latinos) and stage
at diagnosis. To select the best fitting model, we employed a comparative approach
comparing sample-size adjusted BIC and entropy; which indicates a good separation
of classes.
Results:
A four–class solution with an entropy of 0.72 was identified as:
lowest survivorship, medium-low, medium-high, and highest survivorship. The lowest
survivorship class (26% of sample) with a mean survival rate of 53 months had the
highest conditional probabilities of being 76–85 years–old at diagnosis, female, widowed,
and non-Hispanic White, with a high likelihood with localized staging. The highest
survivorship class (53% of sample) with a mean survival rate of 92 months had the highest
likelihood of being married, male with localized staging, and a high likelihood of being
non-Hispanic White.
Conclusion: The use of a person–centered measure with population-based cancer
registries data can help better detect cancer risk subgroups that may otherwise
be overlooked.
Keywords: colorectal (colon) cancer, cancer health disparities, latent class analyses, survivorship (public health),
person-centered analysis
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INTRODUCTION

with data from nine cancer registries in the states of Georgia
(Atlanta), Connecticut, Michigan (Detroit), Hawaii, Iowa, New
Mexico, California (San Francisco), Washington (Seattle-Puget
Sound), and Utah (32). Patients included in this study were nonHispanic Blacks and Whites age ≥18 years diagnosed from 1975
through 2016 with malignant, histologically confirmed primary
colon and rectal cancer under the International Classification of
Diseases for Oncology, Third Edition (ICD-O-3) histology and
behavior code. This study was exploratory and not designed to be
diagnostic in nature.

Colorectal cancer (CRC) remains the third most diagnosed
cancer, and the second leading cause of cancer-related death in
both men and women in the United States (US) (1). There are
an estimated 147,950 new cases and 53,200 deaths expected in
2020, accounting for 8.4% of all cancer deaths (1, 2). Despite
the current estimates, CRC incidence and mortality rates have
been decreasing overall since 2000 (1, 3), while incidence rates
among adults aged ≤50 years have increased since the mid1990s (3–5). The reasons for the decline in CRC incidence and
mortality rates include advancements in biomedical sciences,
leading to early detection and diagnosis, as well as improved
treatment, increased screening outreach on a population basis,
and adherence to interventions on behavioral lifestyle risk factors
like smoking cessation (1, 3).
Regardless of the decline in CRC incidence, mortality, and
survival, geographical and racial/ethnic disparities persist (1,
3, 6–12). For instance, between 1995 and 2014 the lowest
CRC incidence rate was 29.7/100,000 individuals in Utah
while the highest was 49.2/100,000 in Kentucky (1). Similarly,
CRC mortality rates range from 11.0/100,000 population in
Connecticut to 18.3/100,000 population in Mississippi (1). In
terms of race/ethnicity, evidence has shown that non-Hispanic
Blacks and American Indians/Alaska Natives experience the
highest CRC incidence and mortality rates, compared to nonHispanic Whites (1). Therefore, there is critical need for research
to understand these disparities and to inform the development of
interventions to reduce/eliminate them.
The stage of CRC diagnosis is important to treatment,
recovery, and survival (3). According to the American Cancer
Society, the overall 5-year relative rate for localized stage
diagnosis is 90%, regional 71%, distant 14%, and all stages
combined 63% (13). Modifiable and non-modifiable risk factors,
including age, genetics, sedentary lifestyle, and socioeconomic
status (SES) have been known to affect CRC development (7, 14–
16). Several studies have examined differences in CRC incidence,
mortality, and survival by these factors (12, 16–31). Zhang
et al. (31) used the Surveillance, Epidemiology, and End Results
(SEER) data from 2007 to 2013 to investigate the impact of SES
on overall CRC survival. Results revealed that patients with CRC
who were non-Hispanic Black, widowed, on Medicaid, and with
the lowest education had relatively poor prognoses. However,
studies involving the analysis of overall survivorship of patients
with CRC in population subgroups in the US are sparse. As such,
this exploratory study aimed to identify profiles and determine
disparities in malignant CRC survivorship outcomes using SEER
9 cancer registry program incidence databases from 1975 to
2016. The findings will help identify heterogenous, mutually
exclusive profiles and provide important information about how
interventions should be tailored to different subpopulations.

Latent Class Analysis
We used latent class analysis (LCA), a person-centered approach,
to identify latent or hidden profiles in data. LCA transitions us
from variable-centered approaches that examine relationships
between variables to a person-centered context in which we can
further identify subgroups of risk by profile. We conducted an
LCA on SEER 9 data to identify and assess differences in CRC
survivorship by observed indicators of sociodemographic factors
and derived cancer stage. Observed indicators within the profiles
were assessed as conditional probabilities, i.e., likelihood of each
indicator being present within the profile with all other indicators
present. The distal outcome of survivorship was a continuous
measure of survival in total number of months from cancer
diagnosis until recorded all-cause death. An automatic Bolck,
Croon, and Hagenaars (BCH) method in our LCA was used
to account for the distal continuous outcome of survivorship
and assess mean differences by profile identified. This approach
minimizes bias as algorithms, not the researcher, identify profiles
based on observed indicators and survivorship.
Observed indicators from patient sociodemographic
characteristics included in our LCA were age, sex/gender,
race, Hispanic/Latino origin, and marital status. Age at diagnosis
was categorized using the US Preventive Service Task Force
screening age recommendation (33) (i.e., 18–49; 50–75; 76–85;
85 and older). Sex/gender was based on dichotomous male or
female categories, and race was made into three categories. The
first two racial categories included individuals that self-identified
as either White or Black. The third racial category, Other
race, was a combination of participants that self-identified as
American Indian/Alaska Natives and Asian or Pacific Islanders,
based on the SEER race recode changes (34). We included
Hispanic/Latino as a dichotomous yes or no category based
on North American Association of Central Cancer Registries
Hispanic Identification Algorithm (35). Marital status was
categorized as single/never married; married/common law;
divorced/separated; and widow/widower. The derived stage of
CRC was categorized as localized, regional, or distant.

Model Fit Assessment for Latent Class
Analysis
Multiple models were created based on number of classes (i.e.,
1-, 2-, 3-, 4-, 5-class solutions) and compared using the following
criteria: (1) entropy [i.e., the acceptable quality of classification
and indication of good separation of classes]; (2) Bayesian
information criterion (BIC) and sample-size-adjusted BIC (ssaBIC); and (3) theoretical implications (36). This comparative

MATERIALS AND METHODS
Source and Study Population
This study used data from the SEER database of the National
Cancer Institute. The SEER 9 covers ∼10% of the US population
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Latent Class Analysis Subgroups/Profiles
of Survivorship

approach allowed us to select our final model for interpretation
based on high entropy, as well as parsimony assessed via BIC,
ssa-BIC, and practical application. All statistical analyses were
conducted using Mplus 8.4 (Muthén and Muthén).

Class 1, or the lowest survivorship group (26% of sample), had
∼53 months of survival from diagnosis. The lowest survival
group had the highest conditional probabilities of being 76–
85 years old at time of diagnosis (43.8%), female (78.9%), and
widowed (85.2%) and had a high likelihood of being White

RESULTS
Sociodemographic Characteristics
A total of 525,245 patients with malignant CRC were included.
Of these patients, a little over half were males (50.4%), aged 50–
75 years (57%), and married (57%) at the time of CRC diagnosis.
Most of the patients were non-Hispanic White (83.5%) with
localized stage disease (41%). The mean survival time from CRC
diagnosis was 77.3 ± SE months [SE = 0.123, 95% CI: 77.1–77.6]
(Table 1).
Patients’ risk profiles/survival subgroups were identified using
LCA model fit assessment (Table 2). The best model fit selected
was a four-class solution that had a low ssa-BIC (4,662,336.8) and
an entropy of 0.72, which indicated a clear separation of classes
or profiles. The classes were named by relative survival in months
from CRC diagnosis until death from all-cause mortality.

TABLE 2 | Latent class analysis model fit assessment (N = 525,245).
Class

BIC

SSA-BIC

Entropy

1-Class Solution

4831811.6

4831773.4

–

2-Class Solution

4687966.2

4687886.7

0.88

3-Class Solution

4667251.0

4667130.3

0.65

4-Class Solution

4662498.8

4662336.8

0.72

5-Class Solution

4659145.0

4658941.6

0.68

AIC, Akaike Information Criterion; BIC, Bayesian Information Criterion; SSA-BIC, SampleSize Adjusted Bayesian Information Criterion.

TABLE 1 | Sample demographic characteristics (N = 525,245).
N

%

Age at diagnosis
18–49

41,926

8.0

50–75

298,295

56.8

76–85

134,292

25.6

≥86

50,493

9.6

Sex
Male

264,853

50.4

Female

260,392

49.6

White

436,947

83.5

Black

47,912

9.1

Other

38,708

7.4

No

502,892

95.7

Yes

22,353

4.3

Single/never married

54,264

10.8

Married/common law

286,518

57.0

Separated/divorce

44,127

8.8

Widow/widower

117,898

23.4

Localized

199,057

41.5

Regional

182,007

37.9

Distant

98,854

20.6

Race

Hispanic/latino

Marital status

Derived staging

M

Survival in months

77.3

SE

0.123

95% CI
Lower

Upper

77.1

77.6

M, Months; SE, Standard Error; CI, Confidence Interval.
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to the highest survivorship profile. As such, marital status and
sex/gender had the greatest disparity in survivorship. These
findings were consistent with Aizer et al. (37), Jin et al. (38),
Johansen et al. (39), Li et al. (40), and Wang et al. (41) who
reported that married patients with cancer were less likely to
present with CRC metastasis and survived significantly longer,
compared to unmarried and widowed patients.
The profile identified with medium-low survivorship was
found to be exclusively Hispanic/Latino and had the second
highest likelihoods of being diagnosed at a distant stage and
of being between 50 and 75 years. While the medium-low
profile also had the second highest likelihood of being married
(63%) when compared to all other profiles, it also had the
second highest likelihoods of being single/never married and
divorced/separated. The medium-high survivorship profile had
the highest likelihood of being Black when compared to all
other profiles. This profile also had the highest likelihoods of
being single/never married and divorced/separated. Our findings
revealed that disparities in CRC survival outcomes may not be
attributable to race/ethnicity alone, but to other factors related to
marital status for both males and females. Studying the impact
of marriage on CRC stage at diagnosis and survival using SEER
dataset, Li et al. (40) found that CRC cause specific survival
among the married group was almost 70% compared to the never
married (59%), divorced/separated/widowed groups (60%). The
reason for these disparities are attributed to higher rates of
depression, anxiety, medication non-adherence, and negative
emotions among widowed patients (42–44).
Overall, while disparities in CRC mortality and survivorship
have been found in prior studies, our study has expanded
the limited literature concerning CRC disparities using a
person-centered approach. We have identified four heterogenous
survivorship profiles that are affected by multiple interacting
factors, not just by racial/ethnic categories. While prior studies
have found associations in CRC incidence and survival by
race/ethnicity and age group (5, 20, 21, 45–48), these associations
have been found to vary by database. For instance, Gabriel
et al. (20) used the National Cancer Data Base (NCDB) from
2006 to 2012 to analyze CRC differences in demographic
and pathologic factors with age related rates and overall
survival. Results indicated disparities in overall survival, but
African American and Hispanic/Latino patients aged ≤50 years
experienced increased morality (20). In contrast, Murphy et al.
(5) investigated CRC incidence and relative survival using SEER
13 registries data (1992–2014) among younger adults, aged ≤50,
and found that while absolute CRC incidence was higher for
Blacks than Whites, Blacks experienced a slightly higher 5year relative survivorship improvement with colon cancer, and
increased survival with rectal cancer (i.e., from 55.5 to 70.8%) (5).
Racial and ethnic health disparities have long been associated
with CRC disparities, with many persisting if not worsening and
shifting the burden of morbidity and mortality to other medically
underserved and underrepresented groups. Our exploratory,
person-centered study identified racial/ethnic CRC disparities
in survivorship among CRC patients. By identifying the unique
and inextricable context of racial/ethnic groups that may play
a critical role in disease progression may also play a role

(86.8%). This subgroup had the highest conditional probability
of having malignant localized stage disease (40.8%).
Class 2, or the medium-low survivorship group (3% of
sample), had 71.7 months of survival from diagnosis until
death (Table 3). This subgroup had the highest conditional
probabilities of being White (99%), Hispanic/Latino (100%) and
male (58.2%) or female (41.8%). The medium-low survivorship
group had high probabilities of being 50–75 years old at the
time of diagnosis (66.8%), married (63.3%), and of localized stage
CRC (39.3%). In addition, this subgroup had the second highest
probability of regional stage malignant CRC diagnosis (38%).
The Class 3, or medium-high survivorship group represents
17% of the study sample (Table 3). The Class 3 group
also had 73.5 months of survival since diagnosis with the
highest conditional probabilities of being 50–75 (71.0%) years
at diagnosis, single/never married (31.1%), divorced/separated
(22.3%), and Black (25.7%). This group also had an almost equal
probability of being male (52.3%) or female (48.7%) with distant
stage disease (28.1%).
The last risk profile subgroup identified in our LCA is Class
4, or the highest survivorship group (53% of sample), with
91.7 months of survival from diagnosis (Table 3). This subgroup
had the highest conditional probabilities of being male (65.1%),
married/common law marriage (91.7%), and localized stage CRC
diagnosis (44.3%). Class 4 had high probabilities of being between
50 and 75 years old (64.6%) and non-Hispanic White (88.1%).
The highest survivorship group also had the lowest conditional
probability of distant stage disease (17.9%). See Table 3 for
detailed mean survivorship and conditional probabilities.
Equity test of survivorship means across classes using the
automatic BCH procedure with 3 degrees of freedom for overall
test was found significant (x2 = 17587.5, p < 0.001; see
Table 4). That is, mean survivorship was significantly different
between profiles.

DISCUSSION
This study used LCA, a person-centered method, to identify
profiles of survivorship among patients with malignant CRC
in a large population-based SEER cancer registry. This analysis
of more than 525,000 patients with CRC diagnosed between
1975 and 2016 found heterogenous profiles by survivorship,
age at diagnosis, sex/gender, race, ethnicity, marital status,
and cancer derived staging. Four profiles of CRC survivorship
were identified: lowest survivorship (53.0 months), mediumlow survivorship (71.7 months), medium-high survivorship (73.5
months), and highest survivorship (91.7 months).
We identified that the highest survivorship profile (91.7
months; Class 4) had the highest conditional likelihoods of
being married and diagnosed with localized disease, followed
by a high likelihood of being 50–75 years of age, White, and
male. The lowest survivorship profile (Class 1) with 53.0 months
from diagnosis to death had the highest likelihoods of being
female, widowed, older (i.e., 76–85 years of age), and with
regional disease. The lowest survivorship profile also had the
second highest likelihood of localized disease when compared
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TABLE 3 | Latent class analysis of survivability rates among invasive CRC patients (N = 525,245).
Class 1

Class 2

Class 3

Class 4

Lowest survivorship

Medium-low survivorship

Medium-high survivorship

Highest survivorship

138,458

17,438

89,547

279,802

26%

3%

17%

53%

18 - 49

0.000

0.204

0.220

0.0610

50 - 75

0.305

0.668

0.710

0.646

76 - 85

0.438

0.110

0.067

0.241

≥ 86

0.257

0.018

0.003

0.052

Male

0.211

0.582

0.513

0.651

Female

0.789

0.418

0.487

0.349

Single/Never Married

0.074

0.203

0.311

0.043

Married/Common Law

0.000

0.633

0.436

0.917

Divorced/Separated

0.075

0.137

0.223

0.040

Widow/Widower

0.852

0.030

0.030

0.000

White

0.868

0.990

0.647

0.881

Black

0.082

0.000

0.257

0.038

Other

0.05

0.010

0.096

0.081

Age at diagnosis

Sex/Gender

Marital Status

Race

Hispanic
No

0.972

0.000

0.993

0.986

Yes

0.028

1.0000

0.007

0.014

Localized

0.408

0.393

0.353

0.443

Regional

0.390

0.380

0.366

0.379

Distant

0.202

0.227

0.281

0.179

52.959 (0.196)

71.741 (0.859)

73.497 (0.475)

91.700 (0.236)

Derived Staging

Survival in Months

*Color gradient indicates the conditional probabilities ranging from 0 in green to 30% in orange to 60% in lavender to 100% in violet. SE, Standard Error.

prevalence, and outcomes, marital status may be a more reliable
indicator for survivorship in the absence of available contextual
risk factors. For instance, in a Tennessee cancer registry study
by Montiel Ishino et al. (51), among patients with malignant
CRC, White widowed women were found to have the greatest
likelihood of delay for CRC surgical treatment followed by
Blacks regardless of health insurance status when compared to
White married men, i.e., the profile with the lowest likelihood
of surgical treatment delay. Black patients were also more likely
to be single/never married or divorced/separated, with a lower
likelihood of delayed surgical treatment, than White widowed
women. However, they had a higher likelihood of delay when
compared to White married men (51).
Our LCA study is among the first to differentiate between
profiles using the distal continuous outcome of survivorship.
Policy-level and public health recommendations, as well as
clinical implications, can be garnered from our exploratory,
person-centered analysis and findings. Considerations should
be given to improved data collection at cancer registries to

in efficiently and efficaciously addressing CRC disparities. For
instance, we found that the medium-low and medium-high
survivorship profiles had the highest likelihoods to belonging
to an ethnic/racial minority (Hispanic or non-Hispanic Black,
respectively). We observed, however, that in these profiles there
were increased likelihoods of being single/never married or
divorced/separated. Additionally, these profiles had a decreased
likelihood of being diagnosed at a localized stage; especially,
when compared to the lowest and highest survivorship
profiles that were primarily racially White and non-Hispanic.
Epidemiological studies have previously found that minority and
underserved populations, like that of US Blacks, have worse CRC
prognoses compared to Whites (1, 3–5, 7), with only few studies
reporting no significant difference (49, 50).
Our findings revealed that racial/ethnic disparities in the
context of available sociodemographic characteristics have
heterogenous profiles of survivorship based on race/ethnicity but
nuanced by marital status. While cancer registries are expanding
data collection to discern risk factors for cancer incidence,
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and cancer health disparities. We would then examine the
protective and risk factors that may be associated with marital
status, in addition to how psychological characteristics correlate
with survivorship.

TABLE 4 | Equity test survivorship means across classes using BCH procedure
with 3 degrees of freedom for overall test (N = 525,245).

Overall test

Chi-square

p-value

17587.5

0.000

Class 1 vs. 2

449.3

0.000

Class 1 vs. 3

1477.5

0.000

Class 1 vs. 4

15946.4

0.000

Class 2 vs. 3

3.2

0.000

Class 2 vs. 4

486.4

0.000

Class 3 vs. 4

861.9

0.000

Limitations
This study adds to the current literature by identifying how
CRC survival outcome disparities exist using a large populationbased SEER database, as well as differentiating between profiles
to demarcate the extent of the disparity. Nonetheless, a number
of limitations should be addressed. The first is the level of
representativeness to generalize findings to the US population,
although the sample is very large. SEER datasets primarily
include data from White individuals in urban metro areas.
Second, SEER registries do not collect SES variables such as
income, education, employment, health insurance status, as well
as quality of healthcare patients received. In addition, some
sociodemographic variables reported may be inaccurate. For
example, marital status is only collected at the time of diagnosis.
Individuals whose status changed are never updated and other
environmental factors are also not available. Despite these
limitations, the SEER program has a reputation of reporting longterm, high quality incidence, prevalence, and survival data (3).
Currently, the program covers over 28% of the US population,
which serves as a major data source for cancer stage distribution,
stage-specific survival, and lifetime incidence of developing
cancer (54).

BCH, Bolck, Croon, and Hagenaars; DF, Degrees of Freedom.

enhance risk assessments. In this manner, CRC interventional
studies can be designed by leveraging large datasets such as
SEER that are publicly available to better tailor interventions
and prevention programs. Using person-centered methods, we
can move beyond associations between variables to examine
the context of variables among subpopulations. By using these
person-centered approaches, we can better approximate CRC
patient profiles to identify the most salient factors within
profiles and prioritize care and access at a clinical level. In
this manner we can better promote and tailor screenings and
intervene upon factors related to decreased survivorship among
CRC patient subpopulations. For instance, while CRC screening
interventions are in place, the role of marital status must be
further examined within the scope of these interventions to
understand the direct and indirect effects it has on survivorship.
Furthermore, indicators such as SES, access to quality care
and provider expertise must also be assessed to truly capture
a person-centered, multilevel context. However, these factors
were not available in the SEER 9 database. Geographic and
ecological data would have made the person-centered context
much richer by including socioeconomic status (e.g., family
income; education) and environmental exposures (e.g., tobacco
smoke; pollutants).
Our findings indicated that derived stage of CRC alone may
not be sufficient to predict CRC survival outcomes, but rather
it is a constellation of social determinants. It is, therefore,
crucial that while we focus on the social determinants of
health in understanding cancer disparities that we contextually
examine risk factors that interact at the person-level to mitigate
subpopulation disparities and promote health equity. The
relationship between race and cancer survival is a complex
one (52, 53). Several interacting factors including tumor
type, grade, stage, comorbidities, access to healthcare/quality
services, provider expertise, and SES are known to confound
this relationship and contribute to these disparities (1, 3, 15,
46). Regardless, our LCA, using a distal continuous outcome
of survivorship, provides a proof of concept to identify the
complex context of CRC associated variables to account for
multiple complex interactions on possible risk profiles. Future
research directions would explore the effects of race/ethnicity,
social support, and cancer staging to understand the complex
and dynamic interaction of multiple determinants of health
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Conclusions
The use of a person–centered measures such as LCA with
population-based cancer registry data can help better detect
cancer risk subgroups that may otherwise be overlooked.
This study identified four risk subgroups: lowest, mediumlow, medium-high, and highest survivorship subgroups. Of
interest is the fact that racial or sociodemographic disparities
alone do not account for differences in invasive CRC survival.
Hence, this study revealed that Whites have almost equal
chances of both good and poor CRC prognosis while Blacks
continue to experience worse outcomes. Females, Hispanics,
and widowed patients have poorer survival outcomes among
the risk profiles/subgroup identified in this study. Thus, in
developing tailored interventions for CRC, these high-risk
subgroup populations should be considered in order to improve
malignant CRC survivorship.
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